Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach Or Graft alpha/beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL)
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
11-2019
DOI
10.1182/blood-2019-131706
Journal Title
Blood
Department
Pediatrics
Second Department
Health Behavior and Community Health
Recommended Citation
Abdel-Azim, H., Dvorak, C. C., Bunin, N., Walters, M. C., Talano, J., Anderson, E. J., Malvar, J., Jasani, M. A., Chaudhury, S., Cairo, M. S., Kitko, C., Jacob, A. P., Monos, D. S., Wing, L., & Pulsipher, M. A. (2019). Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach Or Graft alpha/beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL). Blood, 134 (Suppl. 1), 4624. https://doi.org/10.1182/blood-2019-131706